Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons
Metformin (Met) is a first-line drug for type 2 diabetes mellitus (T2DM). Numerous studies have shown that Met exerts beneficial effects on a variety of neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). However, it is still largely un...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2020-10-01
|
| シリーズ: | Brain Sciences |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2076-3425/10/10/706 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
